- Conditions
- Osteoporosis, Osteopenia
- Interventions
- Genistein vs Risedronate
- Dietary Supplement
- Lead sponsor
- Purdue University
- Other
- Eligibility
- Female only
- Enrollment
- 23 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2010
- U.S. locations
- 1
- States / cities
- West Lafayette, Indiana
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–16
of 16
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Menopause, Postmenopausal Bone Loss, Breast Cancer
- Interventions
- Tibolone
- Drug
- Lead sponsor
- Dana-Farber Cancer Institute
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 3
- States / cities
- Boston, Massachusetts
- Conditions
- Osteopenia, Osteoporosis
- Interventions
- BPS804 20mg/Kg, Placebo to 20mg/Kg BPS804
- Drug
- Lead sponsor
- Ultragenyx Pharmaceutical Inc
- Industry
- Eligibility
- 45 Years to 85 Years · Female only
- Enrollment
- 44 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 5
- States / cities
- Anaheim, California • Miami, Florida • Berlin, New Jersey + 1 more
- Conditions
- Osteoporosis, Osteopenia, Postmenopausal Osteoporosis
- Interventions
- Moringa Oleifera, Cabbage Placebo
- Dietary Supplement
- Lead sponsor
- Appalachian State University
- Other
- Eligibility
- 60 Years to 70 Years · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- Boone, North Carolina
- Conditions
- Osteoporosis
- Interventions
- zoledronic acid
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 45 Years to 79 Years · Female only
- Enrollment
- 220 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 12
- States / cities
- Santa Rosa, California • Lakewood, Colorado • Gainsville, Florida + 9 more
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- Ibandronate
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- Female only
- Enrollment
- 1,711 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 142
- States / cities
- Birmingham, Alabama • Columbiana, Alabama • Huntsville, Alabama + 128 more
- Conditions
- Osteoporosis
- Interventions
- Raloxifene, Zoledronic acid, Placebo oral pills, Placebo intravenous (i.v.) infusion
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 45 Years to 80 Years · Female only
- Enrollment
- 110 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 17
- States / cities
- Phoenix, Arizona • Buena Park, California • Washington D.C., District of Columbia + 12 more
- Conditions
- Osteopenic Women
- Interventions
- 2 POMx Capsules, 2 placebo Capsules
- Dietary Supplement
- Lead sponsor
- POM Wonderful LLC
- Industry
- Eligibility
- 45 Years to 65 Years · Female only
- Enrollment
- 64 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Osteoporosis, Postmenopausal Bone Loss
- Interventions
- Mediterranean Diet
- Other
- Lead sponsor
- UConn Health
- Other
- Eligibility
- 65 Years and older · Female only
- Enrollment
- 22 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Farmington, Connecticut
- Conditions
- Postmenopausal Bone Loss, Breast Cancer
- Interventions
- Not listed
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2010
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Post-Menopausal Osteopenia
- Interventions
- Placebo, ibandronate [Bonviva/Boniva]
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 45 Years to 60 Years · Female only
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 12
- States / cities
- Lakewood, Colorado • Stuart, Florida • Bethesda, Maryland + 9 more
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- Ibandronate
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- Female only
- Enrollment
- 545 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 60
- States / cities
- Montgomery, Alabama • Lake Havasu City, Arizona • Paradise Valley, Arizona + 53 more
- Conditions
- Breast Cancer
- Interventions
- Physical Evaluation, Dual-energy X-ray absorptiometry scans, Trabecular Bone Score
- Other · Diagnostic Test
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 7
- States / cities
- Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more
- Conditions
- Osteopenia
- Interventions
- Calcium Carbonate, Vitamin D3, Risedronate, Bone-loading exercises
- Drug · Behavioral
- Lead sponsor
- University of Nebraska
- Other
- Eligibility
- 19 Years and older · Female only
- Enrollment
- 276 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 1
- States / cities
- Omaha, Nebraska
- Conditions
- Osteoporosis
- Interventions
- zoledronic acid
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 45 Years to 79 Years · Female only
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 18
- States / cities
- Birmingham, Alabama • San Diego, California • Denver, Colorado + 15 more
- Conditions
- Osteopenia
- Interventions
- zoledronic acid
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 45 Years to 75 Years · Female only
- Enrollment
- 455 participants
- Timeline
- 2004 – 2005
- U.S. locations
- 6
- States / cities
- Unavailable, Georgia • Unavailable, Illinois • Unavailable, Indiana + 3 more